Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CDE vs GSK✓SelectedUSD · GSKCDE vs GSK performance historyLatest closeAs of-7.06%11/18
Stock and ETF performance explorer

CDE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.9%
GSK return
-1.9%
Excess return
-25.0%
Maximum drawdown
-44.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.1%-1.3%-5.7%-7.0%
7D-18.6%-3.1%-15.4%-18.4%
30D-20.2%-0.9%-19.3%-20.1%
3M-33.9%-4.2%-29.7%-33.0%
All-26.9%-1.9%-25.0%-25.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling